STOCK TITAN

Clarivate Plc - CLVT STOCK NEWS

Welcome to our dedicated news page for Clarivate Plc (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Clarivate Plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Clarivate Plc's position in the market.

Rhea-AI Summary
Clarivate Plc partners with the Financial Times for the sixth year to provide high-quality data for business school rankings, including the Global MBA Rankings. The partnership aims to offer valuable insights for students and institutions, leveraging Web of Science data for research ranks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
partnership
-
Rhea-AI Summary
Clarivate Plc (NYSE: CLVT) has successfully completed the refinancing of its term loan B credit facility and extended the maturity date of its revolving credit facility. The company refinanced all existing term loans with a new $2.150 billion tranche of term loans maturing in 2031, with a reduced interest rate margin of 275 basis points per annum. The new term loan facility effectively extends the maturity of the company's existing term loans by approximately 5 years. The new term loans amortize in equal quarterly installments equivalent to 1.00% per annum, with the balance due at maturity. Concurrently, the company's revolving credit facility was refinanced with a replacement $700 million facility, extending the maturity from 2027 to 2029. Jonathan Collins, Executive Vice President and Chief Financial Officer, expressed satisfaction with the outcome, citing the oversubscribed interest in the recent offering as a testament to their solid credit profile and strong cash flow generation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.59%
Tags
none
-
Rhea-AI Summary
Clarivate Plc (NYSE:CLVT) has launched the Web of Science™ Grants Index, providing a comprehensive view of the global funding landscape with 5.2M+ awarded grant records from over 400 funders worldwide. This solution aims to empower researchers to make confident, informed decisions when seeking research funding by offering insights on funder's priorities and previously awarded grants. The integrated solution also enables researchers to identify potential new sources of funding and display details of prior funding alongside scholarly research content. Later this year, researchers will be able to claim awarded grants to their Web of Science Researcher Profiles and present published papers and citations resulting from a grant.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.46%
Tags
none
Rhea-AI Summary
Clarivate Plc (NYSE: CLVT) will report its financial results for the fourth quarter and full year 2023 on February 27, 2024. The company will host a conference call and webcast to review the results. Interested parties can access the live audio broadcast and webcast through the investor relations section of the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.52%
Tags
conferences earnings
-
Rhea-AI Summary
Clarivate Plc (CLVT) announced the launch of a process to refinance its 2026 Term Loan B credit facility, extending the maturity to 2031 for a new combined term loan amount of $2.2 billion. The company also expects to record a non-cash goodwill impairment charge in the range of $800 million to $900 million in the fourth quarter of 2023, across its Intellectual Property and Life Sciences & Healthcare segments. This charge is expected to lower the company's 2023 forecast of a GAAP net loss, but will not impact the 2023 full-year outlook for Revenues, Organic Revenue Growth, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Diluted EPS, and Free Cash Flow. The proposed refinancing is subject to market and other conditions, with no assurance of completion on favorable terms or at all.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
none
-
Rhea-AI Summary
Clarivate Plc (CLVT) Releases Annual Drugs to Watch Report, Predicts 13 New Therapeutics to Achieve Blockbuster Status by 2029
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6%
Tags
none
Rhea-AI Summary
Clarivate Plc (NYSE:CLVT) Launches Electrophysiology Mapping and Ablation Devices Market Insights Report Series, Predicts Pulsed-Field Ablation to Revolutionize EP Mapping and Ablation Device Market
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.31%
Tags
none
-
Rhea-AI Summary
Clarivate Plc (CLVT) launches VeriSIM Life Translational Index™ on Cortellis Drug Discovery Intelligence, providing pharma and biotech companies with predictive compound safety and efficacy insights. The integrated workflow aims to minimize late-stage failures during clinical trials, leveraging AI to reduce research and development time and increase clinically active compound candidates.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
partnership
-
Rhea-AI Summary
Clarivate Plc (NYSE:CLVT) reveals its 2023 list of Highly Cited Researchers™, recognizing influential researchers globally. The evaluation process draws on data from the Web of Science™ citation index, with 6,849 researchers from over 1,300 institutions in 67 nations and regions. Key findings show a concentration of top talent, with 10 countries representing over 80% of the list. The US leads with 37.5%, followed by Mainland China with 17.9%. The Chinese Academy of Sciences tops the list with 270 recognitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
none
Rhea-AI Summary
Clarivate Plc (NYSE: CLVT) announced that CEO Jonathan Gear will present at the RBC Capital Markets 2023 Technology, Internet, Media and Telecommunications Conference on November 14, 2023 at 1:20 pm Eastern Time. The live webcast can be accessed at https://www.veracast.com/webcasts/rbc/tmit2023/67C540.cfm and will be available for replay.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.67%
Tags
conferences
Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Stock Data

4.98B
400.01M
16.61%
92.43%
5.16%
Data Processing, Hosting, and Related Services
Information
Link
United Kingdom
160 Blackfriars Road

About CLVT

clarivate analytics is the global leader in providing trusted insights and analytics to accelerate the pace of innovation. we offer some of the most trusted brands across the innovation lifecycle, including web of science™, cortellis™, derwent™, compumark™, markmonitor® and techstreet™. organizations and researchers rely on the curated knowledge bases from clarivate for information about scientific and academic research, patent analytics, pharmaceutical and biotech intelligence and ip management. an independent company with over 4,000 employees and operations in more than 100 countries, clarivate is on a bold entrepreneurial mission to help radically reduce the time from new ideas to life-changing innovations. for more information, please visit clarivate.com.